The evolving epidemiology of rotavirus gastroenteritis in central Portugal with modest vaccine coverage

Journal of Clinical Virology

Volumn 56, Issue 2, 2013, Pages 129-134

  Rodrigues, Fernanda ^a   Iturriza Gómara, Miren ^b   Marlow, Robin ^c   Gray, Jim ^b   Nawaz, Sameena ^b   Januário, Luís ^a   Finn, Adam ^c  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Acute gastroenteritis; Genotypes; Immunisation; Rotavirus

Indexed keywords

ROTAVIRUS VACCINE;

ACUTE DISEASE; AGE DISTRIBUTION; ARTICLE; CHILD; CHROMATOGRAPHY; FECES ANALYSIS; GASTROENTERITIS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PORTUGAL; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS; SEASON; SPRING; WINTER;

CHILD, PRESCHOOL; FECES; GASTROENTERITIS; GENOTYPE; HUMANS; IMMUNOCHROMATOGRAPHY; INFANT; INFANT, NEWBORN; MOLECULAR EPIDEMIOLOGY; PORTUGAL; RNA, VIRAL; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES;

EID: 84872375219     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.10.016     Document Type: Article

References (22)

1. Parashar U.D., Gibson C.J., Bresse J.S., Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006, 12:304-306.
2. Van Damme P., Giaquinto C., Huet F., Gothefors L., Maxwell M., Van der Wielen M., et al. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007, 195(Suppl. 1):S4-S16.
3. Marlow R.D., Finn A. The promise of immunisation against rotavirus. Arch Dis Child 2012, 97:736-740.
4. Soriano-Gabarro M., Mrukowicz J., Vesikari T., Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006, 25:S7-S11.
5. Payne D.C., Szilagyi P.G., Staat M.A., Edwards K.M., Gentsch J.R., Weinberg G.A., et al. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J 2009, 28:948-953.
6. Santos N., Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005, 15:29-56.
7. Kirkwood C.D., Boniface K., Barnes G.L., Bishop R.F. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix(R) and RotaTeq(R), into the National Immunization Program of Australia. Pediatr Infect Dis J 2011, 30:S48-S53.
8. Tate J.E., Mutuc J.D., Panozzo C.A., Payne D.C., Cortese M.M., Cortes J.E., et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011, 30:S30-S34.
9. Braeckman T., Van Herck K., Raes M., Vergison A., Sabbe M., Van Damme P. Rotavirus vaccines in Belgium: policy and impact. Pediatr Infect Dis J 2011, 30:S21-S24.
10. Tate J.E., Panozzo C.A., Payne D.C., Patel M.M., Cortese M.M., Fowlkes A.L., et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009, 124:465-471.
11. Curns A.T., Steiner C.A., Barrett M., Hunter K., Wilson E., Parashar U.D. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis 2010, 1617-1624.
12. Lambert S.B., Faux C.E., Hall L., Birrell F.A., Peterson K.V., Selvey C.E., et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust 2009, 191:157-160.
13. Paulke-Korinek M., Kundi M., Rendi-Wagner P., de Martin A., Eder G., Schmidle-Loss B., et al. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011, 29:2791-2796.
14. Richardson V., Hernandez-Pichardo J., Quintanar-Solares M., Esparza-Aguilar M., Johnson B., Gomez-Altamirano C.M., et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Eng J Med 2010, 362:299-305.
15. Hull J.J., Teel E.N., Kerin T.K., Freeman M.M., Esona M.D., Gentsch J.R., et al. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J 2011, 30:S42-S47.
16. Rodrigues F., Iturriza M., Gray J., Januario L., Lemos L. Epidemiology of rotavirus in Portugal: G9 as a major cause of diarrhoea in non-hospitalised children. J Clin Virol 2007, 40:214-217.
17. Zeller M., Rahman M., Heylen E., De Coster S., De Vos S., Arijs I., et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vaccine 2010, 28:7507-7513.
18. Raes M., Strens D., Vergison A., Verghote M., Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011, 30:e120-e125.
19. Paulke-Korinek M., Rendi-Wagner P., Kundi M., Kronik R., Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr Infect Dis J 2010, 29:319-323.
20. Pitzer V.E., Viboud C., Simonsen L., Steiner C., Panozzo C.A., Alonso W.J., et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 2009, 325:290-294.
21. Sáfadi M.A.P., Berezin E.N., Munford V., Almeida F.J., de Moraes J.C., Pinheiro C.F., et al. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo. Braz Pediatr Infect Dis J 2010, 29:1019-1022.
22. Räsänen S., Lappalainen S., Salminen M., Huhti L., Vesikari T. Noroviruses in children seen in a hospital for acute gastroenteritis in Finland. Eur J Pediatr 2011, 170:1413-1418.